About
Ocugenix develops disease-modifying therapies targeting eye diseases such as wet age-related macular degeneration, geographic atrophy, proliferative diabetic retinopathy, and dry eye by activating natural wound healing pathways to resolve inflammation, fibrosis, and pathological vessel growth.
Explore Ocugenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.